SCHEMBL21411550

SCHEMBL21411550

N#CCC[C@@H](N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13318957 1.00
SCHEMBL158491 1.00
SCHEMBL30562964 1.00
SCHEMBL2708260 1.00
SCHEMBL3696195 0.88 SLC1A2 (0.62)
SCHEMBL3696199 0.88 SLC1A2 (0.62)
SCHEMBL8530336 0.86 SLC1A2 (0.60)
SCHEMBL8126946 0.86 SLC1A2 (0.60)
SCHEMBL25662044 0.86 SLC1A2 (0.60)
SCHEMBL25660492 0.85 SLC1A2 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11339193-B2 CDP protein secretion inhibitors KEZAR LIFE SCIENCES (US) 2022-05-24 US disclosed
US-11339193-B2 CDP protein secretion inhibitors KEZAR LIFE SCIENCES (US) 2022-05-24 US disclosed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
CN-112513065-A CDP protein secretion inhibitors 科智生命科学公司 2021-03-16 CN disclosed
EP-3774850-A1 CDP PROTEIN SECRETION INHIBITORS Kezar Life Sciences (US) 2021-02-17 EP disclosed
US-20210017233-A1 CDP PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2021-01-21 US disclosed
US-20210017233-A1 CDP PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2021-01-21 US disclosed
WO-2019191527-A1 CDP PROTEIN SECRETION INHIBITORS KEZAR LIFE SCIENCES (US) 2019-10-03 WO disclosed
WO-2019191527-A1 CDP PROTEIN SECRETION INHIBITORS KEZAR LIFE SCIENCES (US) 2019-10-03 WO disclosed